"Consider the price of approved radiopharmaceutical treatments targeting neuroendocrine cancer (Lutathera) and prostate cancer (Pluvicto). Both kill cancer cells with the radioactive isotope lutetium-177, which emits beta particles. "
"Lutathera costs $35,000 per dose, Pluvicto costs $27,000 per dose, with a typical course of treatment for each ranging from four to five doses. "
I assume its Canadian dollars, but might be US$.
Whatever, very expensive.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.46 |
Change
0.090(2.06%) |
Mkt cap ! $1.658B | |||
| Open | High | Low | Value | Volume |
| $4.37 | $4.64 | $4.36 | $19.15M | 4.236M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58340 | $4.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.46 | 365 | 5 |
View Market Depth
| Last trade - 16.15pm 01/08/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |